Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangtang Capsule
- Development stage
- Unknown
- Lead developer
- Buchang Pharmaceuticals
- Administration
- Oral
01
Overview
Jiangtang Capsule is a Traditional Chinese Medicine (TCM) pharmaceutical product developed and manufactured by Shanxi Buchang Pharmaceutical. It is specifically indicated for the treatment of diabetes mellitus. As a TCM formulation, it is composed of multiple botanical extracts intended to regulate blood glucose levels and manage symptoms associated with diabetic conditions. The product is approved for use in China and is positioned within Buchang's specialized portfolio of metabolic health treatments, which also includes related formulations such as Tongmai Jiangtang and Xiaoke Jiangtang.
- Brand names
- Jiangtang Capsule
- Other names
- 降糖胶囊
Beyond the preview
Go deeper on Jiangtang Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangtang Capsule.